BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7381453)

  • 1. CNS tryptamine metabolism in hepatic coma.
    Young SN; Lal S
    J Neural Transm; 1980; 47(3):153-61. PubMed ID: 7381453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan in hepatic coma.
    Sourkes TL
    J Neural Transm Suppl; 1978; (14):79-86. PubMed ID: 290743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid.
    Young SN; Davis BA; Gauthier S
    J Neurol Neurosurg Psychiatry; 1982 Jul; 45(7):633-9. PubMed ID: 6181210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid, lactic acid, and pH before and after probenecid in hepatic coma.
    Lal S; Aronoff A; Garelis E; Sourkes TL; Young SN; de la Vega CE
    Clin Neurol Neurosurg; 1975 Dec; 77(2):142-52. PubMed ID: 236851
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine estimation in cerebrospinal fluid in cases of liver cirrhosis and hepatic coma.
    GILON E; SZEINBERG A; TAUMAN G; BODONYI E
    J Lab Clin Med; 1959 May; 53(5):714-9. PubMed ID: 13654912
    [No Abstract]   [Full Text] [Related]  

  • 7. Trace amines in hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Prog Brain Res; 1995; 106():277-84. PubMed ID: 8584664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid.
    Anderson GM; Gerner RH; Cohen DJ; Fairbanks L
    Biol Psychiatry; 1984 Oct; 19(10):1427-35. PubMed ID: 6518200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid protein concentration in hepatic coma.
    Dillon D; Schenker S
    JAMA; 1972 Jul; 221(5):507. PubMed ID: 5067962
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurotransmitter modifications in human cerebrospinal fluid and serum during hepatic encephalopathy.
    Borg J; Warter JM; Schlienger JL; Imler M; Marescaux C; Mack G
    J Neurol Sci; 1982 Dec; 57(2-3):343-56. PubMed ID: 6186774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy.
    Cascino A; Cangiano C; Fiaccadori F; Ghinelli F; Merli M; Pelosi G; Riggio O; Rossi Fanelli F; Sacchini D; Stortoni M; Capocaccia L
    Dig Dis Sci; 1982 Sep; 27(9):828-32. PubMed ID: 7105954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the determination of glutamine in cerebrospinal fluid and the results in hepatic coma.
    WHITEHEAD TP; WHITTAKER SR
    J Clin Pathol; 1955 Feb; 8(1):81-4. PubMed ID: 14354038
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid indoleacetic acid in autistic subjects.
    Anderson GM; Ross DL; Klykylo W; Feibel FC; Cohen DJ
    J Autism Dev Disord; 1988 Jun; 18(2):259-62. PubMed ID: 3410814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.
    Young SN; Lal S; Sourkes TL; Feldmuller F; Aronoff A; Martin JB
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):322-30. PubMed ID: 1141919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.
    Smith AR; Rossi-Fanelli F; Ziparo V; James JH; Perelle BA; Fischer JE
    Ann Surg; 1978 Mar; 187(3):343-50. PubMed ID: 637594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan and hepatic coma.
    Ono J; Hutson DG; Dombro RS; Levi JU; Livingstone A; Zeppa R
    Gastroenterology; 1978 Feb; 74(2 Pt 1):196-200. PubMed ID: 620892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-selective decreases in densities of [3H]tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
    Mousseau DD; Layrargues GP; Butterworth RF
    J Neurochem; 1994 Feb; 62(2):621-5. PubMed ID: 8294925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of short-chain fatty acids in cirrhosis and hepatic coma.
    Clausen MR; Mortensen PB; Bendtsen F
    Hepatology; 1991 Dec; 14(6):1040-5. PubMed ID: 1959851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF homovanillic acid: an index of dopaminergic activity.
    Curzon G
    Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid.
    Young SN; Gauthier S
    J Neurol Neurosurg Psychiatry; 1981 Apr; 44(4):323-8. PubMed ID: 6165809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.